DigitCells

This month, we're recognizing the individuals and families facing blood cancers like leukemia and lymphoma. Advances in early detection and treatment continue to improve care and outcomes for patients. Take a moment this month to learn the signs, support someone on their journey, or simply spread the word.

Learn more from the American Association for Cancer Research (AACR): https://www.aacr.org/patients-caregivers/awareness-months/leukemia-and-lymphoma-awareness-month/

📍 San Diego, get ready. DigitCells is exhibiting at Pathology Visions 2026, and we're bringing the full TWO-D ecosystem to Booth 610. See how our cassette design protects prostate cores from fragmentation, how core-level analysis captures precise measurements at the grossing station, and how visual mapping brings clarity to every case. From specimen collection to sign-out, TWO-D keeps tissue intact and data connected at every step. Stop by to see the full workflow in action.

Learn more about TWO-D: https://digitcells.com/twod

September marks Urology Awareness Month. Advances in digital pathology are changing how urologic conditions get diagnosed, giving physicians faster and more precise insights. From kidney and bladder concerns to prostate health, earlier detection often starts with better tools behind the scenes. Technology and timely screenings go hand in hand when it comes to catching issues early. This month, we're recognizing the role innovation plays in urologic care.

Big things take effort, and today we're celebrating that. 💪 Whether it's a new idea or a well-earned day off, progress deserves a pause every now and then. Happy Labor Day from DigitCells!

September is Ovarian Cancer Awareness Month. Ovarian cancer symptoms are often subtle, which makes accurate and timely pathology review essential to diagnosis. Common signs like bloating, pelvic pain, or changes in appetite are frequently mistaken for less serious conditions, which can delay detection. When caught early, the five-year survival rate exceeds 90 percent, yet only about 20 percent of cases are diagnosed at this stage. Awareness of these symptoms and consistent follow up with a physician can make a meaningful difference in outcomes.

September is Prostate Cancer Awareness Month, and prostate health often gets less attention than it deserves, even though early detection can change outcomes significantly. This month is a good time to ask questions and stay informed about your own risk factors. Small conversations now can lead to better decisions later, so don't wait for a reason to bring it up with your doctor.

Digital pathology is stepping in where the microscope alone can no longer keep up. This NHS-focused piece explores how AI and cloud-based imaging are helping labs manage rising cancer caseloads and a shrinking pathology workforce. Rather than replacing pathologists, the technology is being positioned as a partner, flagging urgent cases and easing pressure on stretched teams. The result could mean faster diagnoses, better outcomes, and a more sustainable path forward for cancer care.

Read more: https://aijourn.com/from-glass-slides-to-ai-how-digital-pathology-can-transform-cancer-care-in-the-nhs/

From Glass slides to AI: How digital pathology can transform cancer care in the NHS | The AI Journal Every year, millions of pathology slides are produced in the UK, most still examined manually under a microscope. This century-old process, though reliable,

What if a single tissue slide could reveal more without ever running out? Virtual staining is changing how pathologists analyze biomarkers, mapping expression cell by cell while preserving precious tissue for what comes next. This shift means faster answers for clinicians, more data for researchers, and fewer bottlenecks in the path to treatment. As spatial and computational insights become central to diagnosis, the H&E slide is proving to be far more than a starting point.

Read more: https://thepathologist.com/issues/2026/articles/june/virtual-staining-and-the-next-era-of-pathology/

Virtual Staining and the Next Era of Pathology How AI enables scalable biomarker analysis that preserves tissue samples, addressing some of the most persistent bottlenecks in clinical care and research

Digital pathology is moving from "nice to have" to enterprise necessity, but scanners and storage alone won't get labs there. A new review lays out a full lifecycle framework for sustainable DP adoption, covering workflow redesign, validation, interoperability, cybersecurity, and institutional AI readiness. The authors stress a key distinction: regulatory clearance is not the same as laboratory validation and ongoing quality management. For pathology departments navigating the shift to digital, this offers a practical roadmap for building lasting, innovation-ready programs.

Read more:

Strategic framework enables sustainable digital pathology implementation in clinical practice Digital pathology (DP) is transitioning from an adjunct technology to an enterprise diagnostic platform in the United States. Despite accelerating clinical adoption, many laboratories face persistent barriers, including high capital and operating costs, workflow disruption, interoperability challeng...

Happy Fourth of July from the DigitCells team! As America celebrates 250 years, we're reminded that great things happen when curiosity meets purpose. Thankful to be part of a country that never stops pushing forward. Enjoy the holiday!